The Patent Finder
US

Compositions and Methods for Modulation of SMN2 Splicing in a Subject

US 9,926,559 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Isis Pharmaceuticals, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Jan 9, 2034 · High confidence

Filed Jul 9, 2015 as application 14/760,171 · Granted Mar 27, 2018
Base term, 20 years from filing
Today
20 years from filing
2014 2034
Clock starts
Jan 9, 2014
Term ends
Jan 9, 2034
Granted
Mar 27, 2018
base term fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 9, 2014, when application PCT/US2014/010930, the earliest non-provisional in its chain, was filed (this one was filed Jul 9, 2015)Jan 9, 2034High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJan 9, 2034High confidence

This family

Application PCT/US2014/010930PCT application
no patent term
no patent term
US 9,926,559this patent
Jan 2034
Jan 2034
Application 15/907,970Abandoned
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 22, 2016
Reel 37880, frame 409
Isis Pharmaceuticals, Inc.Ionis Pharmaceuticals, Inc.Change of Name
Oct 18, 2016
Reel 40415, frame 295
Ionis Pharmaceuticals, Inc.Biogen Ma Inc.Assignment of Assignor's Interest
May 20, 2026
Reel 74711, frame 207
Bennett, C. Frank; Hung, Gene; Rigo, FrankIsis Pharmaceuticals, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited